Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Furst

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|December 8, 2010
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Marie Robin, Reza Tabrizi, Mohamad Mohty, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell TransplantationArnaud Campidelli, Marie Robin, Thomas Remen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2020
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin LymphomasCatalina Montes de Oca, Luca Castagna, Chiara De Philippis, et al.
British Journal of Haematology|June 26, 2014
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow TransplantationLuciana Tucunduva, Annalisa Ruggeri, Guillermo Sanz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin LymphomaJacopo Mariotti, Raynier Devillier, Stefania Bramanti, et al.
Blood Cancer Journal|February 19, 2024
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trialEolia Brissot, Myriam Labopin, Helene Labussière, et al.
British Journal of Haematology|October 20, 2017
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignanciesAnnalisa Paviglianiti, Annalisa Ruggeri, Fernanda Volt, et al.
Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.
Transplantation and Cellular Therapy|December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation CyclophosphamideJacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Haematologica|June 21, 2011
Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Société Française de Greffe de Moelle et de Thérapie CellulaireDamien Roos-Weil, Philippe Moreau, Hervé Avet-Loiseau, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|December 8, 2010
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Marie Robin, Reza Tabrizi, Mohamad Mohty, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell TransplantationArnaud Campidelli, Marie Robin, Thomas Remen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2020
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin LymphomasCatalina Montes de Oca, Luca Castagna, Chiara De Philippis, et al.
British Journal of Haematology|June 26, 2014
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow TransplantationLuciana Tucunduva, Annalisa Ruggeri, Guillermo Sanz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin LymphomaJacopo Mariotti, Raynier Devillier, Stefania Bramanti, et al.
Blood Cancer Journal|February 19, 2024
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trialEolia Brissot, Myriam Labopin, Helene Labussière, et al.
British Journal of Haematology|October 20, 2017
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignanciesAnnalisa Paviglianiti, Annalisa Ruggeri, Fernanda Volt, et al.
Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.
Transplantation and Cellular Therapy|December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation CyclophosphamideJacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Haematologica|June 21, 2011
Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Société Française de Greffe de Moelle et de Thérapie CellulaireDamien Roos-Weil, Philippe Moreau, Hervé Avet-Loiseau, et al.
Pageof 5